AGM MD Presentation
Filed with ASX · · 24 pages · English
On 6ix: 6ix.com/news/agm-md-presentation
Clarity Pharmaceuticals Ltd. on 6ix
In the deck
Earlier from Clarity Pharmaceuticals
- Clarity signs copper-67 Supply Agreement with Nusano
- Co-PSMA trial achieves primary endpoint
- S&P DJI Announces September 2025 Quarterly Rebalance
- Preliminary Final Report
- Clarity successfully completes $203 million institutional pl
Later from Clarity Pharmaceuticals
- Positive guidance from the US FDA on Cu-64 SARTATE Phase III
- Co-PSMA abstract accepted for oral presentation at EAU
- Co-PSMA abstract accepted for oral presentation at EAU Annual Congress 2026
- SECuRE trial to continue with no modifications to protocol
- SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals